169 McCannC
The findings provide a powerful counterpoint to the challenge of low medication adherence in real-world settings, where many patients stop taking GLP-1s before they can see the full clinical benefit
L-carnitine has numerous positive effects on the body, especially its ability to transport fat to the muscles, which then use that fat as an energy source, allowing your body to efficiently burn fat
This distinction is not semantic wordplay
While there are varying perspectives on this issue, in a viewpoint that I was pleased to co-author with Sam Klein and Kevin Hall just published in JAMA, we suggest that the concern regarding physical frailty or sarcopenia with GLP-1-based medications may not be as grounded as some argue
These risks are theoretical, not documented in human trials, but they are reasons community references include cycle off-periods